Warm autoimmune hemolytic anemia: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 15: Line 15:
{{CMG}}
{{CMG}}


{{SK}} Autoimmune haemolytic anaemia, warm antibody; hemolytic anemia due to warm antibody


==[[Warm autoimmune hemolytic anemia overview|Overview]]==


==Overview==
==[[Warm autoimmune hemolytic anemia historical perspective|Historical Perspective]]==
'''Warm Antibody Autoimmune Hemolytic Anemia''' (AIHA) is the most common of the [[Autoimmune diseases|autoimmune]] [[Hemolysis|hemolytic]] diseases.  About half of the cases are [[idiopathic]], with the other half attributable to a predisposing condition or medications being taken.


==Pathophysiology==
==[[Warm autoimmune hemolytic anemia classification|Classification]]==
The most common [[antibody]] involved in warm antibody AIHA is [[IgG]], though sometimes [[IgA]] is found.  The IgG antibodies attach to a red blood cell, leaving their F<sub>C</sub> portion sticking out.  The F<sub>C</sub> region is recognized and grabbed onto by F<sub>C</sub> receptors found on monocytes and macrophages in the [[spleen]].  These cells will pick off portions of the red cell membrane, almost like they are taking a bite.  The loss of membrane causes the red blood cells to become spherocytes.  Spherocytes are not as flexible as normal RBCs, and will be singled-out for destruction in the red pulp of the spleen as well as other portions of the reticuloendothelial system.  The red blood cells trapped in the spleen cause the spleen to enlarge, leading to the splenomegaly often seen in these patients.


The cause of the autoantibody formation is unknown, but the mechanism for drug-induced destruction is better understood.  There are two models for this: the [[hapten]] model and the autoantibody model.  The hapten model proposes that certain drugs, especially [[penicillin]] and [[cephalosporins]], will bind to the red cell membrane and act as haptens.  Antibodies are created against the cell-drug complex, leading to the destructive sequence described above.  The autoantibody model proposes that, through a mechanism not yet understood, certain drugs will cause antibodies to be made against red blood cells which again leads to the same destructive sequence.
==[[Warm autoimmune hemolytic anemia pathophysiology|Pathophysiology]]==


==Clinical Findings==
==[[Warm autoimmune hemolytic anemia causes|Causes]]==
Laboratory findings include severe [[anemia]], increased mean corpuscular volume (MCV, due to the presence of a large number of young erythrocytes), and [[hyperbilirubinemia]] (from increased red cell destruction) that can be of the conjugated or unconjugated type.
 
==[[Warm autoimmune hemolytic anemia differential diagnosis|Differentiating Warm autoimmune hemolytic anemia from other Diseases]]==
 
==[[Warm autoimmune hemolytic anemia epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Warm autoimmune hemolytic anemia risk factors|Risk Factors]]==
 
==[[Warm autoimmune hemolytic anemia screening|Screening]]==
 
==[[Warm autoimmune hemolytic anemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
Diagnosis is made by a positive direct [[Coombs test]], other lab tests, and clinical examination and history.  The direct Coombs test looks for antibodies attached to the surface of red blood cells.
[[Warm autoimmune hemolytic anemia history and symptoms|History and Symptoms]] | [[Warm autoimmune hemolytic anemia physical examination|Physical Examination]] | [[Warm autoimmune hemolytic anemia laboratory findings|Laboratory Findings]] | [[Warm autoimmune hemolytic anemia serum_haptoglobin_level|Serum Haptoglobin Level]] | [[Warm autoimmune hemolytic anemia chest x ray|Chest X Ray]] | [[Warm autoimmune hemolytic anemia Peripheral_smear|Peripheral Smear]] | [[Warm autoimmune hemolytic anemia ultrasound|Ultrasound]] | [[Warm autoimmune hemolytic anemia other imaging findings|Other Imaging Findings]] | [[Warm autoimmune hemolytic anemia other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Corticosteroids]] and immunoglobulins are two commonly used treatments for warm antibody AIHA. Initial Tx consists of prednisone. If ineffective, [[splenectomy]] should be considered. If refractory to both these therapies, consider rituximab, danazol, cyclosphosphamide, azathioprine, or cyclosporine, High dose intravenous immune globulin may be effective in controlling hemolysis, but the benefit is short lived (1-4 weeks), and the therapy is very expensive.
[[Warm autoimmune hemolytic anemia medical therapy|Medical Therapy]] | [[Warm autoimmune hemolytic anemia surgery|Surgery]] | [[Warm autoimmune hemolytic anemia primary prevention|Primary Prevention]] | [[Warm autoimmune hemolytic anemia secondary prevention|Secondary Prevention]] | [[Warm autoimmune hemolytic anemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Warm autoimmune hemolytic anemia future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==


==References==
[[Warm autoimmune hemolytic anemia case study one|Case #1]]
*Sacher, Ronald A. and Richard A. McPherson. "Wildman's Clinical Interpretation of Laboratory Tests, 11th edition."
*Kumar, Vinay, Abul Abbas, and Nelson Fausto. "Robbins and Cotran Pathologic Basis of Disease."


{{Hematology}}
{{Hematology}}

Latest revision as of 19:44, 21 September 2012

Template:DiseaseDisorder infobox For patient information, click here

Warm autoimmune hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Warm autoimmune hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Serum Haptoglobin Level

Chest X Ray

Peripheral Smear

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Warm autoimmune hemolytic anemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Warm autoimmune hemolytic anemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Warm autoimmune hemolytic anemia

CDC on Warm autoimmune hemolytic anemia

Warm autoimmune hemolytic anemia in the news

Blogs on Warm autoimmune hemolytic anemia

Directions to Hospitals Treating Warm autoimmune hemolytic anemia

Risk calculators and risk factors for Warm autoimmune hemolytic anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Autoimmune haemolytic anaemia, warm antibody; hemolytic anemia due to warm antibody

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Warm autoimmune hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Serum Haptoglobin Level | Chest X Ray | Peripheral Smear | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Hematology


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Warm_autoimmune_hemolytic_anemia&oldid=750818"